NASDAQ
1.49USD
0.00 (+1.34%)
We have scored 11 news catalysts on BioHarvest Sciences Inc. (BHST) over the past 12 months. The biggest single-day move next to one of them came Nov 1, 2025, when BHST closed −8.3%: “BioHarvest Sciences CEO discusses Saffron Tech partnership - ICYMI”. Coverage across the window leans positive (average ticker sentiment +0.61). Most of the impact sits in sector healthcare and geographic supply risk.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
26.2M
P/E
—
EPS
—
Beta
1.38
52W range
1.37-12.8
Day range
1.48–1.55
Open
1.50
Prev close
1.49
Volume
7.2K
Avg volume
44.5K
Dividend
0.00
IPO
2021-01-08
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about BioHarvest Sciences Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for BHST: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services. The company has developed a botanical synthesis platform technology to grow plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, and sale of science-based health and wellness nutraceutical solutions, as well as offering Contract Development and Manufacturing Operation (CDMO) services to third parties in the pharmaceutical, cosmeceutical, and nutrition industries.
